Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
about
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Cost-utility analysis of vorti ...... epressive disorder in Finland.
@en
Cost-utility analysis of vorti ...... epressive disorder in Finland.
@nl
type
label
Cost-utility analysis of vorti ...... epressive disorder in Finland.
@en
Cost-utility analysis of vorti ...... epressive disorder in Finland.
@nl
prefLabel
Cost-utility analysis of vorti ...... epressive disorder in Finland.
@en
Cost-utility analysis of vorti ...... epressive disorder in Finland.
@nl
P2093
P2860
P1476
Cost-utility analysis of vorti ...... epressive disorder in Finland.
@en
P2093
Françoise Diamand
Katarzyna Kolasa
Maria Aalto-Setälä
Mélanie Brignone
Natalya Danchenko
Rosanne Campbell
Sandrine Cure
Taru Hallinen
P2860
P304
P356
10.1080/14737167.2017.1240617
P577
2016-09-29T00:00:00Z